Diadenosine Polyphosphates in Tears of Sjögren Syndrome Patients

Thumbnail Image
Full text at PDC
Publication Date
Peral Cerdá, Assumpta
Pintor, Jesús
Advisors (or tutors)
Journal Title
Journal ISSN
Volume Title
The Association for Research in Vision and Ophthalmology, Inc.
Google Scholar
Research Projects
Organizational Units
Journal Issue
Purpose.: To analyze the levels of diadenosine tetraphosphate (Ap4A) and diadenosine pentaphosphate (Ap5A) in tears of subjects with Sjögren syndrome and to compare them with those in a control group. Methods.: Twelve subjects with a diagnosis of Sjögren syndrome and 20 healthy control subjects were invited to participate in the present study. Schirmer strips were used to measure tear secretion (Schirmer I test) and to collect tears. Ap4A and Ap5A were measured by high-pressure liquid chromatography (HPLC), and a dry eye questionnaire (DEQ) was used to evaluate dry eye symptomatology. Results.: The mean concentrations of Ap4A and Ap5A in the Sjögren syndrome group were 2.54 ± 1.02 and 26.13 ± 6.95 μM, respectively. This group of patients was divided in two subgroups: four patients with normal tear production and eight patients with low tear production. Concentrations of Ap4A, and Ap5A in patients with normal tear production (Schirmer test result, 12.3 ± 1.2 mm) were 0.47 ± 0.20 and 8.03 ± 3.27 μM, respectively. In the patients with low tear production (Schirmer test result, 1.0 ± 0.3 mm), the concentrations were 4.09 ± 1.36 and 39.51 ± 8.46 μM, respectively and in the control group, 0.13 ± 0.03 and 0.04 ± 0.02 μM, respectively. Conclusions.: Patients with Sjögren syndrome have abnormally elevated concentrations of diadenosine polyphosphates, indicating that these compounds could be used in the diagnosis of this disease.
En O.A. en la web del editor
1. Srinivasan S Slomovic AR . Sjogren syndrome. Compr Ophthalmol Update. 2007;8(4):205–212. 2. Vitali C Bombardieri S Jonsson R . Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–558. 3. Pillemer SR Matteson EL Jacobsson LT . Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc. 2001;76(6):593–599. 4. Garcia-Carrasco M Ramos-Casals M Rosas J . Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81(4):270–280. 5. Vescovi P Manfredi M Cimarosti S . Sjogren's syndrome: clinical and therapeutic features: a review of the literature (in Italian). Minerva Stomatol. 2004;53(1–2):1–19. 6. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007;5(2):108–152. 7. Pintor J Carracedo G Alonso MC Bautista A Peral A . Presence of diadenosine polyphosphates in human tears. Pflugers Arch. 2002;443(3):432–436. 8. McLennan AG . Dinucleoside polyphosphates: friend or foe? Pharmacol Ther. 2000;87(2–3):73–89. 9. Peral A Carracedo G Acosta MC Gallar J Pintor J . Increased levels of diadenosine polyphosphates in dry eye. Invest Ophthalmol Vis Sci. 2006;47(9):4053–4058. 10. Pintor J Peral A Hoyle CH . Effects of diadenosine polyphosphates on tear secretion in New Zealand white rabbits. J Pharmacol Exp Ther. 2002;300(1):291–297. 11. Pintor J Bautista A Carracedo G Peral A . UTP and diadenosine tetraphosphate accelerate wound healing in the rabbit cornea. Ophthalmic Physiol Opt. 2004;24(3):186–193. 12. Pintor J Peral A Pelaez T Martin S Hoyle CH . Presence of diadenosine polyphosphates in the aqueous humor: their effect on intraocular pressure. J Pharmacol Exp Ther. 2003;304(1):342–348. 13. Begley CG Chalmers RL Mitchell GL . Characterization of ocular surface symptoms from optometric practices in North America. Cornea. 2001;20(6):610–618. 14. van Bijsterveld OP . Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969;82(1):10–14. 15. Pintor J Torres M Miras-Portugal MT . Carbachol induced release of diadenosine polyphosphates—Ap4A and Ap5A—from perfused bovine adrenal medulla and isolated chromaffin cells. Life Sci. 1991;48(24):2317–2324. 16. Pintor J Diaz-Rey MA Torres M Miras-Portugal MT . Presence of diadenosine polyphosphates—Ap4A and Ap5A—in rat brain synaptic terminals: Ca2+ dependent release evoked by 4-aminopyridine and veratridine. Neurosci Lett. 1992;136(2):141–144. 17. Acosta MC Peral A Luna C Pintor J Belmonte C Gallar J . Tear secretion induced by selective stimulation of corneal and conjunctival sensory nerve fibers. Invest Ophthalmol Vis Sci. 2004;45(7):2333–2336. 18. Begley CG Chalmers RL Abetz L . The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci. 2003;44(11):4753–4761. 19. Barboza MN Barboza GN de Melo GM . Correlation between signals and symptoms of dry eye in Sjogren's syndrome patients (in Portuguese). Arq Bras Oftalmol. 2008;71(4):547–552. 20. Tsubota K Hata S Okusawa Y Egami F Ohtsuki T Nakamori K . Quantitative videographic analysis of blinking in normal subjects and patients with dry eye. Arch Ophthalmol. 1996;114(6):715–720. 21. Cowlen MS Zhang VZ Warnock L Moyer CF Peterson WM Yerxa BR . Localization of ocular P2Y2 receptor gene expression by in situ hybridization. Exp Eye Res. 2003;77(1):77–84. 22. Yerxa BR Mundasad M Sylvester RN Garden JC Cooper M Kellerman DJ . Ocular safety of INS365 ophthalmic solution, a P2Y2 agonist, in patients with mild to moderate dry eye disease. Adv Exp Med Biol. 2002;506:1251–1257. 23. Turner JT Landon LA Gibbons SJ Talamo BR . Salivary gland P2 nucleotide receptors. Crit Rev Oral Biol Med. 1999;10(2):210–224. 24. Schrader AM Camden JM Weisman GA . P2Y2 nucleotide receptor upregulation in submandibular gland cells from the NOD.B10 mouse model of Sjogren's syndrome. Arch Oral Biol. 2005;50(6):533–540. 25. Baker OJ Camden JM Rome DE Seye CI Weisman GA . P2Y2 nucleotide receptor activation upregulates vascular cell adhesion molecule-1 [corrected] expression and enhances lymphocyte adherence to a human submandibular gland cell line. Mol Immunol. 2008;45(1):65–75. 26. Farris RL Stuchell RN Mandel ID . Basal and reflex human tear analysis. I. Physical measurements: osmolarity, basal volumes, and reflex flow rate. Ophthalmology. 1981;88(8):852–857. 27. Versura P Cellini M Torreggiani A Profazio V Bernabini B Caramazza R . Dryness symptoms, diagnostic protocol and therapeutic management: a report on 1,200 patients. Ophthalmic Res. 2001;33(4):221–227.